rs28938171
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_001122681.2(SH3BP2):c.1259G>A(p.Gly420Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G420A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001122681.2 missense
Scores
Clinical Significance
Conservation
Publications
- cherubismInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SH3BP2 | NM_001122681.2 | c.1259G>A | p.Gly420Glu | missense_variant | Exon 9 of 13 | ENST00000503393.8 | NP_001116153.1 | |
| SH3BP2 | NM_001145856.2 | c.1430G>A | p.Gly477Glu | missense_variant | Exon 9 of 13 | NP_001139328.1 | ||
| SH3BP2 | NM_001145855.2 | c.1343G>A | p.Gly448Glu | missense_variant | Exon 9 of 13 | NP_001139327.1 | ||
| SH3BP2 | NM_003023.4 | c.1259G>A | p.Gly420Glu | missense_variant | Exon 9 of 13 | NP_003014.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Fibrous dysplasia of jaw Pathogenic:1Uncertain:1
- -
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 420 of the SH3BP2 protein (p.Gly420Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with cherubism (PMID: 11381256, 19576004). ClinVar contains an entry for this variant (Variation ID: 7553). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SH3BP2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Gly420 amino acid residue in SH3BP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12900899, 23298620). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects SH3BP2 function (PMID: 16786512, 22153077). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at